摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2S,5S,8S,11S)-1,4,7,10-tetrabenzyl-2,5,8,11-tetrakis(4-methoxybenzyl)-1,4,7,10-tetraazacyclododecane | 1160293-95-7

中文名称
——
中文别名
——
英文名称
(2S,5S,8S,11S)-1,4,7,10-tetrabenzyl-2,5,8,11-tetrakis(4-methoxybenzyl)-1,4,7,10-tetraazacyclododecane
英文别名
(2S,5S,8S,11S)-1,4,7,10-tetrabenzyl-2,5,8,11-tetrakis[(4-methoxyphenyl)methyl]-1,4,7,10-tetrazacyclododecane
(2S,5S,8S,11S)-1,4,7,10-tetrabenzyl-2,5,8,11-tetrakis(4-methoxybenzyl)-1,4,7,10-tetraazacyclododecane化学式
CAS
1160293-95-7
化学式
C68H76N4O4
mdl
——
分子量
1013.38
InChiKey
IWJHPZPYLIFNIB-VPUOQKLJSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    14.1
  • 重原子数:
    76
  • 可旋转键数:
    20
  • 环数:
    9.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    49.9
  • 氢给体数:
    0
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Synthesis of Water-Soluble Chiral DOTA Lanthanide Complexes with Predominantly Twisted Square Antiprism Isomers and Circularly Polarized Luminescence
    摘要:
    One-step cyclization of a tetraazamacrocycle 5 with 70% yield in a 25-g scale was performed. Its chiral DOTA derivatives, L4, has similar to 93% of TSAP coordination isomer in its Eu(III) and Yb(III) complexes in aqueous solution. [GdL4](5-) exhibits a high relaxivity, making it a promising and efficient MRI contrast agent. High luminescence dissymmetry factor (g(lum)) values of 0.285 (Delta J = 1) for [TbL3](-) and 0.241 (Delta J = 1) for [TbL4](5-) in buffer solutions were recorded.
    DOI:
    10.1021/acs.inorgchem.9b01799
  • 作为产物:
    描述:
    N-苄氧羰基-L-酪氨酸甲醇 、 sodium tetrahydroborate 、 palladium 10% on activated carbon 、 氢气potassium carbonate对甲苯磺酸三苯基膦偶氮二甲酸二乙酯 作用下, 以 四氢呋喃甲醇乙醇二氯甲烷丙酮乙腈 为溶剂, 反应 176.0h, 生成 (2S,5S,8S,11S)-1,4,7,10-tetrabenzyl-2,5,8,11-tetrakis(4-methoxybenzyl)-1,4,7,10-tetraazacyclododecane
    参考文献:
    名称:
    Synthesis of Water-Soluble Chiral DOTA Lanthanide Complexes with Predominantly Twisted Square Antiprism Isomers and Circularly Polarized Luminescence
    摘要:
    One-step cyclization of a tetraazamacrocycle 5 with 70% yield in a 25-g scale was performed. Its chiral DOTA derivatives, L4, has similar to 93% of TSAP coordination isomer in its Eu(III) and Yb(III) complexes in aqueous solution. [GdL4](5-) exhibits a high relaxivity, making it a promising and efficient MRI contrast agent. High luminescence dissymmetry factor (g(lum)) values of 0.285 (Delta J = 1) for [TbL3](-) and 0.241 (Delta J = 1) for [TbL4](5-) in buffer solutions were recorded.
    DOI:
    10.1021/acs.inorgchem.9b01799
点击查看最新优质反应信息

文献信息

  • Synthesis of chiral polyazamacrocycles of variable ring size
    作者:Seiji Kamioka、Sakae Sugiyama、Takashi Takahashi、Takayuki Doi
    DOI:10.1039/c001228a
    日期:——
    Synthesis and structure elucidation of optically active tri-, tetra-, and penta-azamacrocycles having 4-methoxyphenyl pendants are described. Regioselective ring opening of a nosylaziridine with secondary benzyl amines was repeatedly performed to afford the cyclization precursors. Intramolecular N-alkylation of N-(ω-haloalkyl) nosylamide provided tri-, tetra-, and penta-azamacrocycles. On the basis
    描述了具有4-甲氧基苯基侧基的旋光的三,四和五氮杂大环的合成和结构阐明。重复进行具有仲苄基胺的Nosylaziridine的区域选择性开环,以提供环化前体。N-(ω-卤代烷基)壬基酰胺的分子内N-烷基化提供了三,四和五氮杂ama环。根据我们先前通过X射线单晶分析阐明的四氮杂二十环的研究以及在NMR分析的溶液的基础上,我们得出结论,由于三氟氮杂六环的空间位阻,其主要不是花瓶型构象。 4-甲氧基苯基,但五氮杂双环在CDCl 3和CD 2 Cl 2。但是,五-金刚花环的花瓶型构象不如四-金刚花环中观察到的那样稳定,因为在氘代中观察到了五-金刚花环的构象柔性。苯。
  • Chiral cyclen compounds and their uses
    申请人:THE HONG KONG POLYTECHNIC UNIVERSITY
    公开号:US11357873B2
    公开(公告)日:2022-06-14
    The present invention relates to the preparation of a series of chiral DOTA, DO3A, DO2A, DO1A, cyclen and their metal complexes, which display properties superior to those of previous DOTA-based compounds, and hence are potentially valuable as a platform for diagnostic applications. The chiral DOTAs reveal a high abundance of twisted square antiprism (TSA) geometry favoring them to be used as potential MRI contrast agents, whereas their rapid labelling properties at mild conditions make them excellent candidates for use as radiometal chelators.
    本发明涉及一系列手性 DOTA、DO3A、DO2A、DO1A、cyclen 及其金属配合物的制备,这些配合物显示出优于以往 DOTA 类化合物的特性,因此具有作为诊断应用平台的潜在价值。手性 DOTAs 显示出高丰度的扭曲方形反棱柱(TSA)几何形状,有利于它们用作潜在的核磁共振成像造影剂,而它们在温和条件下的快速标记特性使它们成为放射性金属螯合剂的绝佳候选化合物。
  • WO2018051197A5
    申请人:——
    公开号:WO2018051197A5
    公开(公告)日:2022-06-01
  • Chiral Tetraazamacrocycles Having Four Pendant-Arms
    作者:Seiji Kamioka、Takashi Takahashi、Susumu Kawauchi、Hiroaki Adachi、Yusuke Mori、Kotaro Fujii、Hidehiro Uekusa、Takayuki Doi
    DOI:10.1021/ol9005954
    日期:2009.6.4
    chiral tetraazamacrocycle 9 having four pendant-arms was synthesized by repeating ring opening of an Ns-aziridine with secondary amines, followed by macrocyclization. The structure of 9 has been determined by single crystal X-ray diffraction analysis and NMR studies. Sugar-hybrid molecules 12a-12f were synthesized based on the scaffold 9. NMR study showed that 12a-12f keep the similar conformation as 9 in solution.
  • CHIRAL CYCLEN COMPOUNDS AND THEIR USES
    申请人:THE HONG KONG POLYTECHNIC UNIVERSITY
    公开号:US20210283278A1
    公开(公告)日:2021-09-16
    The present invention relates to the preparation of a series of chiral DOTA, DO3A, DO2A, DO1A, cyclen and their metal complexes, which display properties superior to those of previous DOTA-based compounds, and hence are potentially valuable as a platform for diagnostic applications. The chiral DOTAs reveal a high abundance of twisted square antiprism (TSA) geometry favoring them to be used as potential MRI contrast agents, whereas their rapid labelling properties at mild conditions make them excellent candidates for use as radiometal chelators.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐